93 related articles for article (PubMed ID: 1384335)
1. Midtrimester pregnancy termination: a randomized trial of prostaglandin E2 versus concentrated oxytocin.
Owen J; Hauth JC; Winkler CL; Gray SE
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1112-6. PubMed ID: 1384335
[TBL] [Abstract][Full Text] [Related]
2. Mid-second-trimester labor induction: concentrated oxytocin compared with prostaglandin E2 vaginal suppositories.
Winkler CL; Gray SE; Hauth JC; Owen J; Tucker JM
Obstet Gynecol; 1991 Feb; 77(2):297-300. PubMed ID: 1988897
[TBL] [Abstract][Full Text] [Related]
3. Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination.
Owen J; Hauth JC
Obstet Gynecol; 1996 Jul; 88(1):110-3. PubMed ID: 8684741
[TBL] [Abstract][Full Text] [Related]
4. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
Kirz DS; Haag MK
Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
[TBL] [Abstract][Full Text] [Related]
5. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
Ramsey PS; Savage K; Lincoln T; Owen J
Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
[TBL] [Abstract][Full Text] [Related]
6. Vaginally administered prostaglandin E2 as a first and second trimester abortifacient.
Corson SL; Bolognese RJ
J Reprod Med; 1975 Feb; 14(2):43-6. PubMed ID: 1113258
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 suppositories as a second-trimester abortifacient.
Rakhshani R; Grimes DA
J Reprod Med; 1988 Oct; 33(10):817-20. PubMed ID: 3193412
[TBL] [Abstract][Full Text] [Related]
8. Midtrimester pregnancy termination by intravaginal administration of prostaglandin E2.
Surrago EJ; Robins J
Contraception; 1982 Sep; 26(3):285-94. PubMed ID: 6756775
[TBL] [Abstract][Full Text] [Related]
9. High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.
Nuthalapaty FS; Ramsey PS; Biggio JR; Owen J
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1065-70. PubMed ID: 16157113
[TBL] [Abstract][Full Text] [Related]
10. Second-trimester membrane rupture. Abortion induced with prostaglandin E2 after oxytocin failure.
Atad J; Hallak M; Fruchter O; Borenstein J; Abramovici H
J Reprod Med; 1997 Sep; 42(9):581-4. PubMed ID: 9336755
[TBL] [Abstract][Full Text] [Related]
11. Mid-trimester termination of pregnancy with 16,16-dimethyl-trans-delta 2 PGE1 vaginal pessaries: a comparison with intra- and extra-amniotic prostaglandin E2 administration.
Hill NC; Selinger M; Ferguson J; MacKenzie IZ
Int J Gynaecol Obstet; 1991 Aug; 35(4):337-40. PubMed ID: 1682182
[TBL] [Abstract][Full Text] [Related]
12. Midtrimester abortion in patients with a previous uterine scar.
Debby A; Golan A; Sagiv R; Sadan O; Glezerman M
Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):177-80. PubMed ID: 12860337
[TBL] [Abstract][Full Text] [Related]
13. Midtrimester pregnancy termination with prostaglandin E2 vaginal suppositories.
Hochman M; Laufe LE
J Reprod Med; 1976 May; 16(5):263-8. PubMed ID: 933105
[TBL] [Abstract][Full Text] [Related]
14. Vaginal misoprostol vs. concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination.
Owen J; Hauth JC
J Matern Fetal Med; 1999; 8(2):48-50. PubMed ID: 10090490
[TBL] [Abstract][Full Text] [Related]
15. Midtrimester abortion with urea, prostaglandin F2alpha, laminaria, and oxytocin. A new regimen.
Wilson WB
Obstet Gynecol; 1978 Jun; 51(6):699-701. PubMed ID: 662249
[TBL] [Abstract][Full Text] [Related]
16. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
Robins J; Surrago EJ
J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
[TBL] [Abstract][Full Text] [Related]
17. Midtrimester abortion utilizing intraamniotic prostaglandin F2alpha, laminaria and oxytocin.
Horowitz AJ
J Reprod Med; 1978 Oct; 21(4):236-40. PubMed ID: 739476
[TBL] [Abstract][Full Text] [Related]
18. Hyperosmolar urea for elective midtrimester abortion. Experience in 1,913 cases.
Burkman RT; Atienza MF; King TM; Tonascia JA; Pang JC; Whitmore AJ
Am J Obstet Gynecol; 1978 May; 131(1):10-7. PubMed ID: 645773
[TBL] [Abstract][Full Text] [Related]
19. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
Hagar DL; Valley MT; Rayburn WF; Carey JC
J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 for induction of labor in patients with premature rupture of membranes at term.
Ray DA; Garite TJ
Am J Obstet Gynecol; 1992 Mar; 166(3):836-43. PubMed ID: 1550149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
